The Patent Finder

Pharmaceutical Composition for Preventing or Treating Coronavirus DISEASE-19

Institut Pasteur Korea

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,544,360Pharmaceutical Composition for Preventing or Treating Coronavirus DISEASE-19
In force
 · High confidence
Korea Advanced Institute of Science and Technology and Institut Pasteur KoreaIn forceHigh confidence
Application 19/118,628Antiviral Composition for Coronavirus or Influenza Virus, Using Natural Products, and Use Thereof
Pending
Not granted
Korea Advanced Institute of Science and Technology and Institut Pasteur KoreaPendingNot granted
2 of 2 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
1 of these is in force and held by Institut Pasteur Korea.
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited